NewsBytes Profile picture
Official account of NewsBytes. NewsBytes is India's only explanatory journalism portal.

May 14, 2021, 8 tweets

COVAXIN, developed by the Hyderabad-based firm Bharat Biotech in collaboration with the National Institute of Virology and the ICMR, is India's first approved indigenous COVID-19 vaccine. At least 55 crore doses of COVAXIN would be available by December.
newsbytesapp.com/news/india/cov…

Covishield is the Indian brand name of the vaccine developed by the University of Oxford in partnership with the British-Swedish company AstraZeneca. It is being locally produced by the Serum Institute of India. 75 crore doses of Covishield will be available by the year-end.

Sputnik V, the latest vaccine to be approved by the Indian government, has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology of the Russian Ministry of Health. The government plans to roll out 15.6 crore doses of the vaccine by December. #vaccine

Hyderabad-based pharmaceutical Biological E Limited has developed the BECOV2A vaccine. This vaccine contains purified pieces selected for their ability to stimulate a strong immune response. 30 crore doses of the vaccine will be made available this year.

Zydus Cadila, the Ahmedabad-based pharmaceutical company, has developed a vaccine called ZyCoV-D. This vaccine uses genetic material from a disease-causing virus to trigger an immune response against it. Five crore doses of the three-dose vaccine are expected by December.

NVX-CoV2373, branded Covovax, has been developed by the US-based vaccine maker Novavax and will be made available in India in partnership with the Serum Institute of India. Serum Institute will supply 20 crore doses of Covovax by December. #VaccineShortage #india #COVID19India

Intranasal has been developed by COVAXIN producer Bharat Biotech. It is a nasal vaccine, implying it can be administered through the nose and does not require a needle. Ten crore doses of the vaccine will be rolled out. #vaccine #COVID19India #CoronaSecondWave

Gennova vaccine has been developed by the Pune-based Gennova Biopharmaceuticals Ltd. Six crore doses of this vaccine will be available by December. #VaccineForAll #IndiaFightsCOVID19 #COVIDSecondWaveInIndia #CoronaVaccine

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling